Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03643705 · ClinicalTrials.gov registry record · NA

A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention

A NA study of Hypertension and HIV/AIDS, sponsored by Case Western Reserve University.

Completed
Registry status
NA
Development phase
298
Enrollment target
3
Study locations

NCT03643705: Completed NA study of Hypertension and HIV/AIDS, sponsored by Case Western Reserve University.

NCT03643705 is a NA study of Hypertension and HIV/AIDS that has completed, run by Case Western Reserve University. The registered enrollment target is 298 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03643705, a NA study of Hypertension and HIV/AIDS, has completed, sponsored by Case Western Reserve University.

COMPLETED
Registry status
NA
Development phase
298 participants
Enrollment target
3
Study locations

Study Summary

Strategies to improve uptake of cardiovascular disease preventive therapies among people living with HIV (PLHIV) are urgently needed. This study tests an innovative prevention nurse intervention to extend the HIV/AIDS treatment cascade for the treatment of hypertension and hyperlipidemia among PLHIV on suppressive antiretroviral therapy. This intervention may be scalable as an extension of ongoing HIV/AIDS treatment cascade initiatives in HIV specialty clinics nationwide.

Primary Outcome

Repeated measures across 4 time points (0, 4, 8, and 12 months)

Interventions

  • OTHER Multi-component intervention
  • OTHER General prevention education

Study Locations (3)

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland
  • MetroHealth Medical Center - Cleveland

North Carolina

  • Duke Health - Durham

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2019-09-20
Est. Completion 2023-01-15
Phase NA
Case Western Reserve University

141 total trials

What the finished NCT03643705 record still lists

NCT03643705 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Multi-component intervention is the first listed.

NCT03643705 reports a single indexed study location in Ohio, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03643705 about?

NCT03643705 is a clinical study titled "A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention". Strategies to improve uptake of cardiovascular disease preventive therapies among people living with HIV (PLHIV) are urgently needed. This study tests an innovative prevention nurse intervention to extend the HIV/AIDS treatment cascade for the treatment of hypertension and hyperlipidemia among PLHIV...

What is the current status of trial NCT03643705?

This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2019-09-20. Estimated completion is 2023-01-15.

What conditions does trial NCT03643705 study?

This clinical trial studies the following conditions: Hypertension, HIV/AIDS, Hyperlipidemias.

What interventions are being tested in trial NCT03643705?

The interventions under investigation include: Multi-component intervention (OTHER), General prevention education (OTHER).

Who is sponsoring clinical trial NCT03643705?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03643705 being conducted?

This trial has 3 study locations across North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03643705's enrollment target sits among peer trials

298 181st of 470 higher than 290 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06305624 · 298 participants · NA

    Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

  • NCT06754215 · 298 participants · NA

    Smoking Cessation Intervention Development for Homeless Youth

  • NCT06780111 · 298 participants · Phase 1

    Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

  • NCT07209358 · 298 participants · NA

    EDX110 Randomized Control Trial for Treatment of DFUs

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03643705, the US trial registry maintained by the National Library of Medicine. NCT03643705 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.